How Does Nemluvio Work? Mechanism of Action Explained in Plain English

Nemluvio (nemolizumab-ilto) works differently from most skin medications you may have tried. It doesn't just suppress broad inflammation the way steroids do, and it doesn't block a wide swath of immune signals the way older immunosuppressants do. Nemluvio is a precision tool — one that targets a very specific molecular switch responsible for the relentless itch in prurigo nodularis and atopic dermatitis. Here's how it works.

The Root Cause: What Is IL-31?

IL-31 stands for interleukin-31, a naturally occurring protein (cytokine) produced by immune cells called T helper 2 (Th2) cells. Scientists have identified IL-31 as a key driver of the "neuroimmune itch cycle" — the feedback loop between the immune system and nerve fibers in the skin that produces the intense, chronic itching characteristic of prurigo nodularis and atopic dermatitis.

When IL-31 is overproduced (as it is in both PN and AD), it binds to receptors on nerve fibers in the skin, telling those fibers to fire itch signals to the brain. At the same time, IL-31 promotes skin inflammation, disrupts the skin barrier (epidermal dysregulation), and contributes to fibrosis — the hardening and thickening of skin seen in prurigo nodularis nodules.

How Nemluvio Stops the Itch Cycle

Nemluvio is a humanized IgG2 monoclonal antibody that selectively binds to the IL-31 receptor alpha (IL-31RA) on cell surfaces. Think of it this way: IL-31 is a key trying to fit into a lock (the IL-31 receptor) on nerve and skin cells. When the key enters the lock, the itch alarm goes off. Nemluvio blocks the lock — it fits into the receptor so tightly that IL-31 can no longer bind, and the itch signal cannot be transmitted.

Because IL-31 signaling drives so much of the neuroimmune itch cycle, blocking this single receptor has downstream effects on:

Pruritus (itch) — direct reduction in itch signaling through sensory nerve fibers

Skin inflammation — reduction in proinflammatory cytokine release downstream of IL-31

Epidermal barrier function — improvement in the skin barrier that IL-31 had been disrupting

Fibrosis (in PN) — reduction in the hardening and thickening of skin nodules over time

Why Is IL-31 Blocking Better Than Broad Immunosuppression?

Traditional immunosuppressants like cyclosporine and methotrexate work by broadly dampening your immune system. This is effective but comes with significant risks: increased susceptibility to infections, toxicity to organs like the kidneys and liver, and long-term safety concerns.

Nemluvio is not an immunosuppressant. By targeting only IL-31RA, it leaves the rest of your immune system intact. Your body's ability to fight infections and respond to vaccines (except live vaccines) remains largely unaffected. This targeted approach is why Nemluvio has a favorable safety profile with no boxed warnings.

How Nemluvio Differs from Dupixent and Other Biologics

Other biologics approved for eczema and PN work on different pathways in the same inflammatory cascade:

Dupixent (dupilumab): Blocks IL-4 and IL-13 receptors — cytokines involved in inflammation upstream of IL-31

Adbry (tralokinumab) and Ebglyss (lebrikizumab): Block only IL-13

Nemluvio (nemolizumab): Blocks IL-31RA directly — the cytokine most directly responsible for sending itch signals through nerve fibers

Because IL-31 is considered the primary "itch cytokine," Nemluvio's direct targeting of the IL-31 receptor may explain why it can provide itch relief as early as 48 hours after the first injection — faster than some other biologics that work through upstream pathways.

The Pharmacokinetics: How Long Does It Stay in Your System?

Nemluvio is administered by subcutaneous injection and absorbed into the bloodstream, where it circulates and reaches skin tissue. Its terminal elimination half-life is approximately 18.9 days, meaning it takes about 19 days for the body to eliminate half of a given dose. With monthly dosing, steady-state concentrations are achieved after a few months of treatment. The drug is degraded like endogenous immunoglobulin (IgG), primarily through cellular catabolism.

For more information about Nemluvio's uses and dosing, see our guide on what Nemluvio is used for. If you need help locating your Nemluvio through a specialty pharmacy, medfinder can help identify which pharmacies near you can fill your prescription.